| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.05 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.39 | 0.05 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.08 | 0.06 |